- FT NewsFT News
- Press releasesPress releases
- Nestlé considers fate of past deals before striking again
- Novartis to buy French nuclear medicine group AAA
- Novartis/Advanced Accelerator: hot metal type
- Novartis delays Alcon spin off until 2019
- Novartis's new chief sets sights on 'productivity revolution'
- UK start-up Autolus starts 'living medicine' cancer trials
- Novartis names chief to replace Jimenez who is to step down
- Novartis: doctor in the house
- Week in Review, September 2
- Novartis's new $475,000 cancer drug among most expensive ever
Markit short selling activity
Data delayed at least 20 minutes.